Sale!

Mycoplasma Hominis RNA Detection Qualitative Test

Original price was: $176.Current price is: $148.

-16%

The Mycoplasma Hominis RNA Detection Qualitative Test is a cutting-edge molecular diagnostic tool that identifies Mycoplasma hominis infections in the genital tract using Real-Time PCR technology. This test specifically detects the presence of Mycoplasma hominis RNA, providing highly accurate results for diagnosing genital infections and related complications. The test is essential for individuals experiencing symptoms like unusual discharge, pelvic pain, or urinary discomfort, as well as for those with recurrent infections or fertility concerns. At just $148 USD, this advanced testing offers rapid results within 36-48 hours, enabling prompt treatment and preventing potential complications. Early detection through this test can help manage symptoms effectively and reduce the risk of transmission to partners.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Mycoplasma Hominis RNA Detection Qualitative Test

Understanding Mycoplasma Hominis RNA Detection

The Mycoplasma Hominis RNA Detection Qualitative Test represents a significant advancement in molecular diagnostics for genital tract infections. Mycoplasma hominis is a common bacterial pathogen that can colonize the urogenital tract and cause various clinical conditions. Unlike traditional culture methods that may take days to yield results, this innovative test utilizes Real-Time Polymerase Chain Reaction (PCR) technology to detect the presence of Mycoplasma hominis RNA with exceptional accuracy and speed.

This sophisticated diagnostic approach is particularly valuable because Mycoplasma hominis infections can often be asymptomatic or present with non-specific symptoms, making them challenging to diagnose through conventional methods. The test’s ability to detect RNA provides superior sensitivity compared to DNA-based tests, as RNA detection indicates active infection and ongoing bacterial replication rather than mere presence of the organism.

What Does the Test Detect?

The Mycoplasma Hominis RNA Detection Qualitative Test specifically identifies the presence of Mycoplasma hominis ribosomal RNA in clinical specimens. This advanced molecular detection method offers several key advantages:

  • High Sensitivity: Detects even low levels of Mycoplasma hominis RNA
  • Specific Identification: Accurately distinguishes Mycoplasma hominis from other similar organisms
  • Active Infection Detection: RNA presence indicates current, active infection rather than past exposure
  • Rapid Results: Provides conclusive findings within 36-48 hours

Who Should Consider This Test?

This test is recommended for individuals experiencing symptoms or conditions that may indicate Mycoplasma hominis infection:

Symptoms and Clinical Indications

  • Unusual genital discharge or discomfort
  • Pelvic pain or abdominal discomfort in women
  • Urethral discharge or burning during urination in men
  • Recurrent urinary tract infections
  • Pelvic inflammatory disease symptoms
  • Infertility evaluation
  • Post-coital bleeding or discomfort
  • Persistent genital irritation without clear cause

Risk Factors

  • Multiple sexual partners
  • Recent change in sexual partners
  • History of sexually transmitted infections
  • Immunocompromised individuals
  • Women of reproductive age
  • Individuals with recurrent genital infections

Benefits of Mycoplasma Hominis RNA Detection Testing

Choosing the Mycoplasma Hominis RNA Detection Qualitative Test offers numerous advantages for accurate diagnosis and effective treatment:

Clinical Benefits

  • Early Detection: Identifies infections before complications develop
  • Accurate Diagnosis: Provides definitive results to guide appropriate treatment
  • Treatment Guidance: Helps healthcare providers select the most effective antibiotics
  • Prevention of Complications: Early detection can prevent pelvic inflammatory disease, infertility, and other serious conditions
  • Partner Management: Enables appropriate testing and treatment of sexual partners

Practical Advantages

  • Fast Turnaround: Results available within 36-48 hours
  • Non-Invasive Sampling: Simple specimen collection from genital tract
  • High Accuracy: 99% detection rate with Real-Time PCR technology
  • Cost-Effective: Affordable testing at only $148 USD
  • Nationwide Availability: Accessible across all major US cities

Understanding Your Test Results

Interpreting your Mycoplasma Hominis RNA Detection test results is straightforward with proper guidance:

Positive Result

A positive result indicates the presence of Mycoplasma hominis RNA in your specimen, confirming an active infection. This finding should be discussed with your healthcare provider who will recommend appropriate antibiotic treatment. It’s important to complete the full course of prescribed medication and consider testing for sexual partners to prevent reinfection.

Negative Result

A negative result means no Mycoplasma hominis RNA was detected in your sample. However, if symptoms persist, your healthcare provider may recommend additional testing for other potential causes of your symptoms. False negatives are rare with this advanced PCR technology but can occur if the specimen was collected improperly or during very early stages of infection.

Follow-up Recommendations

  • Discuss all results with your healthcare provider
  • Follow prescribed treatment regimens completely
  • Consider retesting after treatment completion if symptoms persist
  • Practice safe sexual behaviors to prevent reinfection
  • Inform sexual partners about positive results for their testing and treatment

Test Pricing and Booking Information

Test Description Price (USD)
Mycoplasma Hominis RNA Detection Qualitative Test $148
Regular Price $176
Discount Savings $28

Nationwide Testing Availability

We have conveniently located testing centers across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.

Pre-Test Instructions

To ensure accurate results, please follow these preparation guidelines:

  • Bring a signed consent document for the Mycoplasma Hominis RNA Detection Qualitative Test
  • Provide any relevant clinical history or previous test results
  • Avoid urinating for at least one hour before specimen collection
  • Refrain from sexual intercourse for 24-48 hours before testing
  • Avoid using vaginal medications, douches, or spermicides for 48 hours prior to testing

Take Control of Your Reproductive Health Today

Don’t let uncertainty about genital infections affect your quality of life and reproductive health. The Mycoplasma Hominis RNA Detection Qualitative Test provides the clarity you need for proper diagnosis and treatment. With our advanced Real-Time PCR technology, rapid turnaround times, and affordable pricing, there’s no reason to delay getting the answers you deserve.

Ready to schedule your test? Contact us today:

Phone: +1(267) 388-9828

Availability: Results delivered within 36 hours by phone or 48 hours by email

Our compassionate healthcare professionals are ready to assist you with testing, answer your questions, and provide the support you need throughout the process. Take the first step toward better reproductive health by booking your Mycoplasma Hominis RNA Detection test today.